Form 4: TherapeuticsMD Director Tommy G. Thompson Acquires Additional Shares

Director Tommy G. Thompson reports purchasing 325 shares of TherapeuticsMD, Inc. at an average price of $1.0018 on April 14, 2025.

Summary

• On April 14, 2025, Tommy G. Thompson, a director of TherapeuticsMD, Inc. (TXMD), acquired 325 shares of common stock at a weighted average price of $1.0018.
• The shares were purchased in multiple transactions with prices ranging from $0.99 to $1.05.
• Following the transaction, Mr. Thompson directly owns 21 shares and indirectly owns 14,779 shares through Thompson Family Holdings, LLC, and 14,312 shares through Thompson Family Investments, LLC.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but the small number of shares purchased doesn't indicate a strong conviction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's value and future.

Stakeholder Impact

• The purchase could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

TherapeuticsMD, TXMD, Tommy G. Thompson, Director, Stock Purchase, Form 4, Beneficial Ownership, Securities